Hematologic Oncology Update cover image

Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network

Hematologic Oncology Update

00:00

Venetoclax plus anti‑CD20 outcomes

She compares venetoclax‑obinutuzumab outcomes, median PFS, and tradeoffs of fixed‑duration therapy versus continuous BTK.

Play episode from 04:49
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app